The role of pemetrexed in recurrent epithelial ovarian cancer: A scoping review.

Roche M, Parisi L, Li L, Knehans A, Phaeton R, Kesterson JP

Open source

DOI
10.4081/oncol.2018.346
Published
2018 Jan 30
Container
Oncology reviews
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4081/oncol.2018.346,
  title = {The role of pemetrexed in recurrent epithelial ovarian cancer: A scoping review.},
  author = {Roche M and Parisi L and Li L and Knehans A and Phaeton R and Kesterson JP},
  year = {2018},
  journal = {Oncology reviews},
  doi = {10.4081/oncol.2018.346},
  url = {https://doi.org/10.4081/oncol.2018.346}
}

RIS

TY  - JOUR
TI  - The role of pemetrexed in recurrent epithelial ovarian cancer: A scoping review.
AU  - Roche M
AU  - Parisi L
AU  - Li L
AU  - Knehans A
AU  - Phaeton R
AU  - Kesterson JP
PY  - 2018
JO  - Oncology reviews
DO  - 10.4081/oncol.2018.346
UR  - https://doi.org/10.4081/oncol.2018.346
ER  - 

APA

M, R., L, P., L, L., A, K., R, P., & JP, K. (2018). The role of pemetrexed in recurrent epithelial ovarian cancer: A scoping review.. Oncology reviews. https://doi.org/10.4081/oncol.2018.346

Source records